Logo Image
News
All NewsPractice Management
Media
All VideosExpert InterviewsPodcastsMedical World NewsPeer ExchangeInsightsCase StudiesCase of the QuarterClinical ForumsPractice OwnershipRapid ReadoutShortsVideo SeriesWhat’s Your WhEYE?
Conferences
Conference CoverageConference ListingConference Recaps
Blog
More
Publications
Digital EditionSupplements And Featured PublicationsiTech
Partners
Resources
Job BoardSponsored
CE

Subscribe

  • News
  • Media
  • Conferences
  • Blog
  • Publications
  • Partners
  • Resources
  • Subscribe
  • CE
  • AMD
  • Allergy
  • Blepharitis
  • COVID-19
  • Cataract
  • Comanagement
  • Comprehensive Eye Exams
  • Conjunctivitis
  • Contact Lenses
  • Cornea
  • DME
  • Diabetic Eye Disease
  • Dry Eye
  • Geographic Atrophy
  • Glasses
  • Glaucoma
  • LASIK
  • Lens Technology
  • Lid and Lash
  • Myopia
  • Nutrition
  • OCT
  • Ocular Surface Disease
  • Optic Relief
  • Patient Care
  • Pediatrics
  • Presbyopia
  • Ptosis
  • Refractive Surgery
  • Retina
  • Technology
  • Therapeutic Cataract & Refractive
Spotlight -
Geographic Atrophy|
Myopia
Advertisement

Arthur B. Epstein, OD, FAAO

Advertisement

Articles by Arthur B. Epstein, OD, FAAO

IPL: The science of comfort and safety

ByArthur B. Epstein, OD, FAAO
July 27th 2020

Key features of current IPL systems make this dry eye therapy better than ever

Overlooked causes of dry eye

ByArthur B. Epstein, OD, FAAO
September 24th 2019
Advertisement

Latest Updated Articles

  • IPL: The science of comfort and safety
    IPL: The science of comfort and safety

    July 27th 2020

  • Overlooked causes of dry eye
    Overlooked causes of dry eye

    September 24th 2019



Advertisement
Advertisement

Trending on Optometry Times - Clinical News & Expert Optometrist Insights

1

More than monitoring: Using AMD visits to promote healthy vision aging

2

FDA approves Brytly eye drops for ocular redness relief lasting up to 12 hours

3

BIM-IOL System holds 37% IOP reduction at 4 years in first-in-human trial

4

Brepocitinib for noninfectious uveitis meets all phase 3 trial end points

5

Study: OCTA analysis tools report different macular vessel density values for glaucoma

  • Advertise
  • About Us
  • Editorial
  • Contact Us
  • Job Board
  • Terms & Conditions
  • Privacy
  • Do not sell my Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Ophthalmology Times
  • Modern Retina
  • Optometry Times
  • Ophthalmology Times Europe
Collaborative Care Symposium
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us